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2 to blossom, giving rise to predictions that the 3D bioprinting market will reach an 47 estimated market size of 1.82 billion dollars by 2022 [8] . 48 The main focus of the majority of 3D bioprinting research and development 49 lies in the fabrication of human tissues/organs that structurally and functionally 50 resemble their native counterparts. To achieve this, different biocompatible 51 materials ranging from naturally-derived to chemically-synthesized polymers -52 including their modifications and composite materials -are being extensively 53 investigated as potential bioinks for 3D bioprinting [9, 10] . Naturally-derived 54 matrices, such as Matrigel® or alginate, are currently the only commercially 55 available option for tissue engineering, although these materials are not able to fully 56 reconstitute natural tissue. Furthermore, Matrigel® as itself is not suitable as a 57 bioink, requiring modifications or blending with other compounds such as agarose 58 for 3D bioprinting [11] . Therefore, the development of fully synthetic designer 59 matrices that can successfully be used as bioinks, poses as a new hallmark in the 60 field of bioprinting. These synthetic designer matrices not only can be manipulated 61 to reassemble specific biological matrices, but can also be made "smart" by changing 62 their structural or functional properties as a response to different biological cues, 63 which are important for cellular proliferation, matrix remodeling or disease 64
progression [12] . These functionalized materials, combined with 3D bioprinting 65 technologies, can revolutionize the way of achieving the complex architecture of 66 tissues/organs, and could also improve the integration, degradability or even the 67 function of the newly synthesized construct. 68
In this review, we will only briefly discuss the currently used techniques in 69 3D bioprinting, and rather focus on promising novel biomaterials that can be 70 functionalized and used for more advanced tissue engineering and regenerative 71 medicine applications. We will further discuss different approaches to obtain smart 72 and responsive scaffolds, and will finally mention current endeavors to bring 3D 73 bioprinting from an in vitro to an in situ approach. with the regeneration process and should be solidified in a non-cytotoxic way. 92 M A N U S C R I P T In microextrusion-based systems, the printed cell-containing material is 159 extruded through a nozzle or needle onto a substrate in a layer-by-layer mode of 160 action. Because of the continued extrusion and filament formation, the bioink should 161 exert enough viscosity for the printing process to happen. Finally, the mechanical 162 integrity of the 3D structure is achieved by UV/visible light or chemical crosslinking 163 methods [14] . Microextrusion allows good control over the material flow, the 164 printing space and can utilize bioinks with very high cell densities. Although being 165 the most used technique for bioprinting, it still faces challenges, particularly the lack 166 of resolution and the shear stress at the tip of the nozzles, that causes cell 167 deformation and cell death [14] . 168
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Inkjet-based systems function in a similar way, but instead of relying on a 169 continuous flow of bioink, they work mostly in a drop-on-demand fashion, ejecting 170 bioink droplets onto the substrate. The drop formation can be achieved through 171 thermal, electrostatic, piezoelectric, electrohydrodynamic, acoustic or solenoid 172 valve action at the nozzle. Upon drop formation, the printing can be performed 173 through a continuous and uninterrupted stream of droplets or by drop-on-demand. 174
It is a relatively low-cost method and allows the creation of gradients of cells or 175 other biomolecules incorporated in the bioink via drop size or density [22] . Other 176 than tissue engineering, the application of this technique is particularly relevant to 177 the fabrication of biosensors and biochips. Due to the force required to eject the 178 droplets, this method is limited by the viscosity of the material used. Also, because 179 the biomaterial needs to be in a liquid state during printing, it has to form a stable 180 3D structure upon crosslinking immediately after deposition, which often slows 181 down the printing process. Finally, this technique is not compatible with biologically 182 relevant cell concentrations, but only feasible when using low cell densities [22, 23] . 183 M A N U S C R I P T crosslinking strategy to give structural stability to the 3D constructs. The first 293 crosslinking step involved calcium-induced complexation of alginate to allow 294 enough structural stability during the printing process, whereas in the second step, 295 UV exposure was used to covalently photocrosslink GelMA, which permanently fixed 296 the printed structure. By including endothelial and stem cells in the bioink, this 297 approach was able to create highly organized perfusable vessels, biomimetizing 298 vasculature [44] . However, the influence of UV exposure on the fate of the cells 299 remains to be investigated, particularly for long term applications. In another study, 300 the lack of structural fidelity of alginate was reduced by blending it with 301 nanocellulose, which allowed to print a suitable hydrogel capable of supporting 302 chondrocyte growth and proliferation, using an electromagnetic inkjet printing 303 technique [45] . Chung and his group intriguingly showed that an alginate-based 304 bioink could be functionalized by combining it with M13 phages modified to display 305 integrin-binding and calcium binding domains in their coat proteins. The modified 306 phage suspension was also able to polymerize alone upon calcium crosslinking due 307 to the calcium binding domain incorporation and was stable for weeks when 308 incorporated in alginate gels. This composite was printed by pneumatic 309 microextrusion with high fidelity while keeping high cell viability and proliferation, 310 due to the added adhesion domain, and promoting osteogenic differentiation of 311 bone precursor cells [46] . Again, the use of viral phages, although modified to 312 nonpathogenic ones, is not ideal for human use. By using human plasma as a source 313 of fibrin, Cubo & Garcia combined it with human fibroblast and keratinocytes to 314 achieve a printed bilayered skin structure. Constructs were printed using a 315 microextrusion piston-based system comprising four syringes. By mixing the plasma 316 with fibroblasts and CaCl2 solution in the extrusion head, a fibrin hydrogel was 317 formed, followed by deposition of a monolayer of keratinocytes. The constructs 318
were transplanted into immunodeficient mice and showed high integration with the 319 native tissue [34] . Using a similar approach, but with fibrinogen isolated from 320 M A N U S C R I P T BioAssemblyBot® printer, which relies on a 6-axis robotic arm and up to 8 bioinks 334 to achieve highly complex constructs in a quick and controlled way. Also, Kang and 335 colleagues recently showed their integrated tissue-organ printer (ITOP) system, 336 able to fabricate real scale tissue constructs of any shape, using a multi-dispensing 337 module approach of synthetic biodegradable polymers to confer mechanical support 338
and composite hydrogels for cell delivery, all in an integrated and user-friendly 339 procedure [47] . Exploring the full potential of 3D bioprinting, the field has already 340 branched to higher and more complex strategies. 4D bioprinting adds "time" as a 341 factor in the printing process, and not time of printing, but rather the ability of 342 constructs to respond and behave in a programmed way over time, after printing. 343
Using approaches as cell-origami or tunable sol-gel transitions, printed materials 344 are able to self-assemble into 3D structures over time in response to pH, 345 temperature or osmolarity and have a wide range of biomedical applications [48] . 346
Using such strategies already enabled the creation of structures using living cells to 347 self-assemble bilayered "vessel-like" constructs or structures able to self-348 fold/unfold for drug or cell delivery [49, 50] . As medicine gets more and more 349 personalized and targeted, in situ printing will appear in the near future. 
